The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma
Abstract
Diffuse large B-cell lymphoma (DLCL) is characterized by a marked degree of morphologic and clinical heterogeneity. We studied 156 patients with de novo DLCL for rearrangements of the BCL2, BCL6, and MYC oncogenes by Southern blot analysis and BCL2 protein expression. We related these data to the primary site of presentation, disease stage, and other clinical risk factors. Structural alterations of BCL2, BCL6, and MYC were detected in 25 of 156, 36 of 116, and 10 of 151 patients, respectively. Three cases showed a combination of BCL2 and BCL6 rearrangements, and two cases had a combination of BCL6 and MYC rearrangements. BCL2 rearrangement was found more often in extensive (39%) and primary nodal (17%) lymphomas than in extranodal cases (4%) (P = .003). BCL2 rearrangement was present in none of 40 patients with stage I disease, but in 22% of patients with stage II to IV (P = .006). The presence of BCL2 rearrangements did not significantly affect overall survival (OS) or disease-free survival (DFS). In contrast, high BCL2 protein expression adversely affected both OS (P = .008) and DFS (P = .01). BCL2 protein expression was poorly correlated with BCL2 rearrangement: only 52% of BCL2-rearranged lymphomas and 37% of BCL2-unrearranged cases had high BCL2 protein expression. Rearrangement of BCL6 was found more often in patients with extranodal (36%) and extensive (39%) presentation versus primary nodal disease (28%). No significant correlation was found with disease stage, lymphadenopathy, or bone marrow involvement. DFS and OS were not influenced by BCL6 rearrangements. MYC rearrangements were found in 16% of primary extranodal lymphomas, versus 2% of primary nodal cases (P = .02). In particular, gastrointestinal (GI) lymphomas (5 of 18 cases, 28%) were affected by MYC rearrangements. The distinct biologic behavior of these extranodal lymphomas was reflected by a high complete remission (CR) rate: 7 of 10 patients with MYC rearrangement attained complete remission and 6 responders remained alive for more than 4 years, resulting in a trend for better DFS (P = .07). These data show the complex nature of molecular events in DLCL, which is a reflection of the morphologic and clinical heterogeneity of these lymphomas. However, thus far, these genetic rearrangements fail as prognostic markers. © 1998 by The American Society of Hematology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, N., Jaffe, E., Stein, H., Banks, P., Chan, J., Cleary, M., Delsol, G., De Wolf- Peeters, C., Falini, B., & Gatter, K. (1994) · Blood · doi:10.1182/blood.v84.5.1361.1361 · Cited by 6,327
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291402 · Cited by 4,949
Report of the Committee on Hodgkin's Disease Staging Classification.
Carbone, P. P., Kaplan, H. S., Musshoff, K., Smithers, D. W., & Tubiana, M. (1971) · PubMed · Cited by 4,166
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
Molecular thanatopsis: a discourse on the BCL2 family and cell death
Yang, E., & Korsmeyer, S. (1996) · Blood · doi:10.1182/blood.v88.2.386.bloodjournal882386 · Cited by 1,332
Tsujimoto, Y., Gorham, J., Cossman, J., Jaffe, E., & Croce, C. M. (1985) · Science · doi:10.1126/science.3929382 · Cited by 991
Zech, L., Haglund, U., Nilsson, K., & Klein, G. (1976) · International Journal of Cancer · doi:10.1002/ijc.2910170108 · Cited by 848
The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation
Ye, B. H., Cattoretti, G., Shen, Q., Zhang, J., Hawe, N., Waard, R. D., Leung, C., Nouri-Shirazi, M., Orazi, A., Chaganti, R. S. K., et al. (1997) · Nature Genetics · doi:10.1038/ng0697-161 · Cited by 820
Gascoyne, R. D., Adomat, S. A., Krajewski, S., Krajewska, M., Horsman, D. E., Tolcher, A. W., O'Reilly, S. E., Hoskins, P., Coldman, A. J., Reed, J. C., et al. (1997) · Blood · doi:10.1182/blood.v90.1.244 · Cited by 509
Hermine, O., Haioun, C., Lepage, E., d'Agay, M., Briere, J., Lavignac, C., Fillet, G., Salles, G., Marolleau, J., Diebold, J., et al. (1996) · Blood · doi:10.1182/blood.v87.1.265.265 · Cited by 452
Kerckaert, J.-P., Deweindt, C., Tilly, H., Quief, S., Lecocq, G., & Bastard, C. (1993) · Nature Genetics · doi:10.1038/ng0993-66 · Cited by 427
BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor.
Chang, C. C., Ye, B. H., Chaganti, R. S., & Dalla-Favera, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.6947 · Cited by 424
p53 mutation is associated with progression in follicular lymphomas
Sander, C., Yano, T., Clark, H., Harris, C., Longo, D., Jaffe, E., & Raffeld, M. (1993) · Blood · doi:10.1182/blood.v82.7.1994.1994 · Cited by 392
Rearrangement of the bcl-6 Gene as a Prognostic Marker in Diffuse Large-Cell Lymphoma
Offit, K., Coco, F. L., Louie, D. C., Parsa, N. Z., Leung, D., Portlock, C., Ye, B. H., Lista, F., Filippa, D. A., Rosenbaum, A., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407143310202 · Cited by 364
p53 mutations are associated with histologic transformation of follicular lymphoma
Lo Coco, F., Gaidano, G., Louie, D., Offit, K., Chaganti, R., & Dalla-Favera, R. (1993) · Blood · doi:10.1182/blood.v82.8.2289.2289 · Cited by 364
Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma.
Migliazza, A., Martinotti, S., Chen, W., Fusco, C., Ye, B. H., Knowles, D. M., Offit, K., Chaganti, R. S., & Dalla-Favera, R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12520 · Cited by 354
Ott, G., Katzenberger, T., Greiner, A., et al. (1997) · PubMed · Cited by 342
Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma
Lo Coco, F., Ye, B., Lista, F., Corradini, P., Offit, K., Knowles, D., Chaganti, R., & Dalla-Favera, R. (1994) · Blood · doi:10.1182/blood.v83.7.1757.1757 · Cited by 317
Hill, M., MacLennan, K., Cunningham, D., Vaughan Hudson, B., Burke, M., Clarke, P., Di Stefano, F., Anderson, L., Vaughan Hudson, G., Mason, D., et al. (1996) · Blood · doi:10.1182/blood.v88.3.1046.1046 · Cited by 314
Bastard, C., Deweindt, C., Kerckaert, J., Lenormand, B., Rossi, A., Pezzella, F., Fruchart, C., Duval, C., Monconduit, M., & Tilly, H. (1994) · Blood · doi:10.1182/blood.v83.9.2423.2423 · Cited by 309
bcl-2 and Other Genomic Alterations in the Prognosis of Large-Cell Lymphoma
Yunis, J. J., Mayer, M. G., Arnesen, M. A., Aeppli, D. P., Oken, M. M., & Frizzera, G. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904203201605 · Cited by 292
Hematopoietic Malignancies Demonstrate Loss-of-Function Mutations ofBAX
Meijerink, J. P. P., Mensink, E. J. B. M., Wang, K., Sedlak, T. W., Slöetjes, A. W., de Witte, T., Waksman, G., & Korsmeyer, S. J. (1998) · Blood · doi:10.1182/blood.v91.8.2991.2991_2991_2997 · Cited by 286
Ye, B. H., Chaganti, S., Chang, C. C., Niu, H., Corradini, P., Chaganti, R. S., & Dalla-Favera, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00311.x · Cited by 277
de Jong, D., Voetdijk, B. M. H., Beverstock, G. C., van Ommen, G. J. B., Willemze, R., & Kluin, P. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805263182106 · Cited by 249
Self-citationMYC rearrangements in histologically progressed follicular lymphomas
Yano, T., Jaffe, E., Longo, D., & Raffeld, M. (1992) · Blood · doi:10.1182/blood.v80.3.758.758 · Cited by 233
Mutations in the First Exon Are Associated with Altered Transcription of c- myc in Burkitt Lymphoma
Cesarman, E., Dalla-Favera, R., Bentley, D., & Groudine, M. (1987) · Science · doi:10.1126/science.3685977 · Cited by 221
BCL2 Overexpression Associated With Chromosomal Amplification in Diffuse Large B-Cell Lymphoma
Monni, O., Joensuu, H., Franssila, K., Klefstrom, J., Alitalo, K., & Knuutila, S. (1997) · Blood · doi:10.1182/blood.v90.3.1168 · Cited by 212
Kramer, M. H., Hermans, J., Parker, J., Krol, A. D., Kluin-Nelemans, J. C., Haak, H. L., van Groningen, K., van Krieken, J. H., de Jong, D., & Kluin, P. M. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.7.2131 · Cited by 201
Self-citationMutations of p53 gene and their relation to disease progression in B- cell lymphoma
Ichikawa, A., Hotta, T., Takagi, N., Tsushita, K., Kinoshita, T., Nagai, H., Murakami, Y., Hayashi, K., & Saito, H. (1992) · Blood · doi:10.1182/blood.v79.10.2701.2701 · Cited by 163
DNA copy number changes in diffuse large B-cell lymphoma--comparative genomic hybridization study
Monni, O. M., Joensuu, H., Franssila, K., et al. (1996) · Blood · doi:10.1182/blood.v87.12.5269.bloodjournal87125269 · Cited by 155
Translocations involving band 3q27 and Ig gene regions in non-Hodgkin's lymphoma [see comments]
Bastard, C., Tilly, H., Lenormand, B., Bigorgne, C., Boulet, D., Kunlin, A., Monconduit, M., & Piguet, H. (1992) · Blood · doi:10.1182/blood.v79.10.2527.2527 · Cited by 134
Otsuki, T., Yano, T., Clark, H., Bastard, C., Kerckaert, J., Jaffe, E., & Raffeld, M. A. (1995) · Blood · doi:10.1182/blood.v85.10.2877.bloodjournal85102877 · Cited by 126
MYC rearrangement and translocations involving band 8q24 in diffuse large cell lymphomas
Ladanyi, M., Offit, K., Jhanwar, S., Filippa, D. A., & CHAGANTI, R. S. K. (1991) · Blood · doi:10.1182/blood.v77.5.1057.1057 · Cited by 120
Jacobson, J. O., Wilkes, B. M., Kwiatkowski, D. J., Medeiros, L. J., Aisenberg, A. C., & Harris, N. L. (1993) · Cancer · doi:10.1002/1097-0142(19930701)72:1<231::aid-cncr2820720141>3.0.co;2-5 · Cited by 114
Tang, S., Visser, L., Hepperle, B., Hanson, J., & Poppema, S. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.1.149 · Cited by 110
Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas
Tanaka, S., Louie, D., Kant, J., & Reed, J. (1992) · Blood · doi:10.1182/blood.v79.1.229.229 · Cited by 101
Muramatsu, M., Akasaka, T., Kadowaki, N., Ohno, H., Yamabe, H., Edamura, S., Doi, S., MORI, T., Okuma, M., & Fukuhara, S. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.d01-1728.x · Cited by 60
BCL6 Gene Rearrangement and Other Cytogenetic Abnormalities in Diffuse Large Cell Lymphoma
Offit, K., Louie, D. C., Parsa, N. Z., Roy, P., Leung, D. H. Y., Lo‐Coco, F., Zelenetz, A. D., Dalla‐Favera, R., & Chaganti, R. S. K. (1995) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199509054757 · Cited by 36
Cited by
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Hans, C. P. (2004) · Blood · doi:10.1182/blood-2003-05-1545 · Cited by 3,703
Shipp, M. A., Ross, K. N., Tamayo, P., Weng, A. P., Kutok, J. L., Aguiar, R. C. T., Gaasenbeek, M., Angelo, M., Reich, M., Pinkus, G. S., et al. (2002) · Nature Medicine · doi:10.1038/nm0102-68 · Cited by 2,428
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
Hummel, M., Bentink, S., Berger, H., Klapper, W., Wessendorf, S., Barth, T. F. E., Bernd, H.-W., Cogliatti, S. B., Dierlamm, J., Feller, A. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055351 · Cited by 1,006
Prediction of Survival in Diffuse Large-B-Cell Lymphoma Based on the Expression of Six Genes
Lossos, I. S., Czerwinski, D. K., Alizadeh, A. A., Wechser, M. A., Tibshirani, R., Botstein, D., & Levy, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032520 · Cited by 911
Metadata
- Authors
- Kramer, M. H. H., Hermans, J., Wijburg, E., Philippo, K., Geelen, E., van Krieken, J. H. J. M., de Jong, D., Maartense, E., Schuuring, E., & Kluin, P. M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1998-11-01
- Volume
- 92
- Issue
- 9
- Pages
- 3152-3162
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2139204503
- Cited by
- 499
- References
- 38
- FWCI
- 10.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.